Lisen Arnheim Dahlström
Affiliated to Research
| Docent
E-mail: lisen.arnheim.dahlstrom@ki.se
Visiting address: Nobels väg 12a, 17165 Stockholm
Postal address: C8 Medicinsk epidemiologi och biostatistik, C8 MEB III, 171 77 Stockholm
About me
- * Bachelor of Science (Hons) in Biomedical Sciences, Manchester Metropolitan
University, England. Major in Medical Microbiology.
* Doctor of Philosophy (PhD in Infectious Disease Control (Smittskydd),
Department of Microbiology, Tumor and Cell biology, Karolinska Institutet.
Title of Thesis: Immunological responses in genital HPV infection and
etiology of cervical cancer
Research
- My research is within infectious disease epidemiology and has a main focus on
prerequisites for optimal vaccination strategies. As vaccination is one of
our most important tools in the combat of infectious disease it is important
to maintain public trust. One way of doing this is to evaluate vaccine
effectiveness and safety on a population-based level. We have in the past
decades reduced the infectious disease burden with vaccination and we are now
facing a situation where younger generations who never confronted the actual
disease tend to shift their focus toward adverse events instead leading to
anti-vaccine movements and misunderstandings about real and perceived risks.
Further, with antibiotic resistance we need to develop new vaccines that need
to be evaluated on a population-based level.
In addition to this I am also involved in several projects optimizing
cervical cancer prevention through both vaccination and screening. In our
group we use sophisticated population-based register matching and modelling
methods in combination with lab and questionnaire data to evaluate:
1) Short and long term vaccine safety and effectiveness to ensure the
reliability of the vaccines
2) Infectious disease burden to investigate both effectiveness and
cost-effectiveness of vaccine programmes
3) Cervical screening setting and recommendations in a changing reality, as
the HPV vaccine and new screening techniques will change the program we have
today.
*Ongoing research projects*
* ACCES Advancing Cervical Cancer Eradication Strategies [1]
*Selected publications*
Association of varying number of doses of quadrivalent human papillomavirus
vaccine with incidence of condyloma. [2]
Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, /et al/
/JAMA 2014 Feb- 311(6):597-603/
A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed
in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
[3]
Lind A, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, /et
al/
/J. Autoimmun. 2014 May - 50():99-106/
Autoimmune, neurological, and venous thromboembolic adverse events after
immunisation of adolescent girls with quadrivalent human papillomavirus
vaccine in Denmark and Sweden: cohort study. [4]
Arnheim-Dahlström L, Pasternak B, Svanström H, Sparén P, Hviid A
/BMJ 2013 Oct - 347():f5906/
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national
cohort study. [5]
Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, /et
al/
/J. Natl. Cancer Inst. 2013 Apr - 105(7):469-74/
Risk of presentation to hospital with epileptic seizures after vaccination
with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine
(Pandemrix): self controlled case series study. [6]
Arnheim-Dahlström L, Hällgren J, Weibull CE, Sparén P
/BMJ 2012 Dec - 345():e7594/
[1] https://ki.se/en/meb/acces
[2] https://www.ncbi.nlm.nih.gov/pubmed/ 24519299
[3] https://www.ncbi.nlm.nih.gov/pubmed/ 24485154
[4] https://www.ncbi.nlm.nih.gov/pubmed/ 24108159
[5] https://www.ncbi.nlm.nih.gov/pubmed/ 23486550
[6] https://www.ncbi.nlm.nih.gov/pubmed/ 23274350
Articles
-
Article: SUPPORTIVE CARE IN CANCER. 2022;30(11):9101-9108
-
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2022;118:34-43
-
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(1):63-73
-
Article: PLOS ONE. 2021;16(10):e0256642
-
Article: VACCINE. 2020;38 Suppl 2:B31-B37
-
Article: PREVENTIVE MEDICINE. 2020;131:105944
-
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2020;99(2):175-185
-
Article: RESPIRATORY MEDICINE. 2019;155:72-78
-
Article: VACCINE. 2019;37(31):4401-4406
-
Article: PULMONARY THERAPY. 2019;5(1):55-68
-
Article: CONTRACEPTION. 2019;99(4):217-221
-
Article: PREVENTIVE MEDICINE. 2019;120:26-33
-
Article: SEXUALLY TRANSMITTED INFECTIONS. 2018;94(7):522-527
-
Article: VACCINE. 2018;36(43):6373-6378
-
Article: VACCINE. 2018;36(41):6202-6211
-
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(2):154-165
-
Article: VIRAL IMMUNOLOGY. 2017;30(8):590-600
-
Article: BMJ OPEN. 2017;7(6):e015021
-
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2017;96(3):286-294
-
Article: EUROPEAN JOURNAL OF CANCER PREVENTION. 2017;26(2):170-178
-
Article: GENES AND IMMUNITY. 2017;18(2):75-81
-
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2017;216(3):264.e1-264.e7
-
Article: JOURNAL OF INTERNAL MEDICINE. 2016;280(6):618-626
-
Article: AUTOIMMUNITY. 2016;49(6):421-433
-
Article: BMC INFECTIOUS DISEASES. 2016;16(1):419
-
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(12):2867-2874
-
Article: BMJ-BRITISH MEDICAL JOURNAL. 2016;352:i276
-
Article: PLOS ONE. 2016;11(4):e0154296
-
Article: BMC INFECTIOUS DISEASES. 2015;15:488
-
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(10):djv185
-
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):264-276
-
Article: EUROPEAN JOURNAL OF CANCER. 2015;51(8):950-968
-
Article: VACCINE. 2015;33(14):1673-1681
-
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(5):1171-1180
-
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(2):350-359
-
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2015;313(1):54-61
-
Article: PLOS ONE. 2015;10(7):e0134185
-
Article: VACCINE. 2014;32(39):4945-4953
-
Article: JOURNAL OF AUTOIMMUNITY. 2014;50:99-106
-
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2014;311(6):597-603
-
Article: BMJ-BRITISH MEDICAL JOURNAL. 2014;348:g130
-
Article: PLOS ONE. 2014;9(1):e82222
-
Article: BMJ-BRITISH MEDICAL JOURNAL. 2013;347:f5906
-
Article: VACCINE. 2013;31(40):4448-4458
-
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2013;105(7):469-474
-
Article: VACCINE. 2013;31(8):1246-1254
-
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2013;22(1):150-158
-
Article: BMJ-BRITISH MEDICAL JOURNAL. 2012;345:e7594
-
Article: JOURNAL OF INFECTIOUS DISEASES. 2012;206(6):860-866
-
Article: VACCINE. 2012;30(19):3042-3046
-
Article: JOURNAL OF ADOLESCENT HEALTH. 2012;50(2):204-206
-
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(12):2541-2550
-
Article: BMJ-BRITISH MEDICAL JOURNAL. 2011;343:d3908
-
Article: PLOS ONE. 2011;6(6):e20624
-
Article: VACCINE. 2010;28(47):7492-7500
-
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;127(8):1923-1930
-
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010;19(10):2469-2478
-
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(2):500-507
-
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;116(1):110-115
-
Article: HLA. 2005;65(3):252-259
-
Article: VIROLOGY. 2004;322(1):182-189
- Show more
All other publications
-
Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(11):1159-1165
-
Letter: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):311-312
-
Review: JOURNAL OF INTERNAL MEDICINE. 2015;278(4):335-353
-
Letter: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2014;311(23):2439-2440
-
Review: CURRENT OPINION IN ONCOLOGY. 2014;26(1):120-129
Employments
- Affiliated to Research, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2022-2024
Degrees and Education
- Docent, Karolinska Institutet, 2013
- Doctor Of Philosophy, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2005